Sanjana Basu is an Investor at Radical Ventures since 2019. Sanjana believes in the deeply disruptive power of AI to create value across the stack and enjoys working with technically differentiated teams building AI businesses across verticals. Her investments include Nabla Bio, Orbital Materials, PocketHealth, Signal 1, Synex, Lisa Health, and Ubenwa.
Before joining Radical, Sanjana was an investor in deep tech, consumer tech, and fintech at the Venture arm of the Tata Group in India. Before that, she was an investment banker at Barclays.
Born and raised in Mumbai, India, she completed her MBA from the Indian Institute of Management, Bangalore (IIM-B), and her undergraduate in Economics & International Relations from Tufts University in Boston, US.
